These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 20102506
1. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. Bernay F, Bland JM, Häggström J, Baduel L, Combes B, Lopez A, Kaltsatos V. J Vet Intern Med; 2010; 24(2):331-41. PubMed ID: 20102506 [Abstract] [Full Text] [Related]
2. Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study. Lefebvre HP, Ollivier E, Atkins CE, Combes B, Concordet D, Kaltsatos V, Baduel L. J Vet Intern Med; 2013; 27(5):1083-91. PubMed ID: 23869534 [Abstract] [Full Text] [Related]
3. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R. J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016 [Abstract] [Full Text] [Related]
4. Re: Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. Kittleson MD, Bonagura JD. J Vet Intern Med; 2010; 24(6):1245-6; author reply 1247-8. PubMed ID: 21054535 [No Abstract] [Full Text] [Related]
5. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, Hanson PD. J Am Vet Med Assoc; 1998 Dec 01; 213(11):1573-7. PubMed ID: 9838955 [Abstract] [Full Text] [Related]
6. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST). Coffman M, Guillot E, Blondel T, Garelli-Paar C, Feng S, Heartsill S, Atkins CE. J Vet Intern Med; 2021 Jul 01; 35(4):1673-1687. PubMed ID: 34028078 [Abstract] [Full Text] [Related]
7. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs. Schuller S, Van Israël N, Vanbelle S, Clercx C, McEntee K. J Vet Pharmacol Ther; 2011 Aug 01; 34(4):322-31. PubMed ID: 20950346 [Abstract] [Full Text] [Related]
8. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease. Thomason JD, Rockwell JE, Fallaw TK, Calvert CA. J Vet Cardiol; 2007 Nov 01; 9(2):103-8. PubMed ID: 17983885 [Abstract] [Full Text] [Related]
9. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group. J Vet Intern Med; 1995 Nov 01; 9(4):234-42. PubMed ID: 8523320 [Abstract] [Full Text] [Related]
10. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group. J Vet Intern Med; 1995 Nov 01; 9(4):243-52. PubMed ID: 8523321 [Abstract] [Full Text] [Related]
11. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial. Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P. J Vet Intern Med; 2016 Nov 01; 30(6):1765-1779. PubMed ID: 27678080 [Abstract] [Full Text] [Related]
12. Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols. Bagardi M, Locatelli C, Zanaboni A, Galizzi A, Malchiodi D, Brambilla PG. Pol J Vet Sci; 2021 Mar 01; 24(1):109-118. PubMed ID: 33847106 [Abstract] [Full Text] [Related]
13. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure. Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K. J Vet Intern Med; 2013 Mar 01; 27(6):1452-62. PubMed ID: 24128373 [Abstract] [Full Text] [Related]
14. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Häggström J, Hansson K, Karlberg BE, Kvart C, Madej A, Olsson K. Am J Vet Res; 1996 Nov 01; 57(11):1645-52. PubMed ID: 8915446 [Abstract] [Full Text] [Related]
15. Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial. Wess G, Kresken JG, Wendt R, Gaugele J, Killich M, Keller L, Simak J, Holler P, Bauer A, Küchenhof H, Glaus T. J Vet Intern Med; 2020 Nov 01; 34(6):2232-2241. PubMed ID: 32945575 [Abstract] [Full Text] [Related]
16. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. de Madron E, King JN, Strehlau G, White RV. Can Vet J; 2011 Nov 01; 52(11):1219-25. PubMed ID: 22547843 [Abstract] [Full Text] [Related]
17. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. Atkins CE, Keene BW, Brown WA, Coats JR, Crawford MA, DeFrancesco TC, Edwards NJ, Fox PR, Lehmkuhl LB, Luethy MW, Meurs KM, Petrie JP, Pipers FS, Rosenthal SL, Sidley JA, Straus JH. J Am Vet Med Assoc; 2007 Oct 01; 231(7):1061-9. PubMed ID: 17916031 [Abstract] [Full Text] [Related]
18. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease. Ames MK, Atkins CE, Eriksson A, Hess AM. J Vet Cardiol; 2017 Jun 01; 19(3):218-227. PubMed ID: 28576479 [Abstract] [Full Text] [Related]
19. DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study. Borgarelli M, Ferasin L, Lamb K, Bussadori C, Chiavegato D, D'Agnolo G, Migliorini F, Poggi M, Santilli RA, Guillot E, Garelli-Paar C, Toschi Corneliani R, Farina F, Zani A, Dirven M, Smets P, Guglielmini C, Oliveira P, Di Marcello M, Porciello F, Crosara S, Ciaramella P, Piantedosi D, Smith S, Vannini S, Dall'Aglio E, Savarino P, Quintavalla C, Patteson M, Silva J, Locatelli C, Baron Toaldo M. J Vet Cardiol; 2020 Feb 01; 27():34-53. PubMed ID: 32032923 [Abstract] [Full Text] [Related]
20. [Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study]. Biller B, Hörauf A, Kraft W. Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Feb 01; 26(1):21-30. PubMed ID: 9531670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]